ALKERMES reported $383.44M in Current Liabilities for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acadia Pharmaceuticals ACAD:US $ 95.33M 14.04M
Amgen AMGN:US $ 14585M 1716M
Biogen BIIB:US $ 4211.6M 864.4M
Biomarin Pharmaceutical BMRN:US $ 443.34M 13.31M
Bluebird Bio BLUE:US $ 247.76M 41.45M
Bristol Myers Squibb BMY:US $ 18991M 1661M
Coherus Biosciences CHRS:US $ 287.05M 29.45M
Eli Lilly And LLY:US $ 15093.2M 3379M
Gilead Sciences GILD:US $ 10214M 509M
Gw Pharmaceuticals GWPH:US $ 160.25M 0.44M
H. Lundbeck A/S LUN:DC 8.44B 474M
Heron Therapeutics HRTX:US $ 82.14M 18.77M
Horizon Pharma HZNP:US $ 852.81M 78.97M
Intra Cellular Therapies ITCI:US $ 50.42M 10.72M
IONIS PHARMACEUT IONS:US $ 293.82M 1.28M
JAZZ PHA JAZZ:US $ 880.59M 128.5M
Marinus Pharmaceuticals MRNS:US $ 16.69M 0.57M
Minerva Neurosciences NERV:US $ 4.44M 1.08M
Nektar Therapeutics NKTR:US $ 131.02M 7.39M
Neurocrine Biosciences NBIX:US $ 212.9M 22.9M
Otsuka Holdings 4578:JP Y 417942M 1519M
Regeneron Pharmaceuticals REGN:US $ 3732.4M 514.6M
Revance Therapeutics RVNC:US $ 58.25M 7.41M
Teva Pharmaceutical Industries TEVA:US $ 12691M 602M
Vertex Pharmaceuticals VRTX:US $ 1836.45M 107.6M
Zogenix ZGNX:US $ 69.34M 10.81M